These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 24875250)
1. Association of serum levels of CEA, CA199, CA125, CYFRA21-1 and CA72-4 and disease characteristics in colorectal cancer. Zhong W; Yu Z; Zhan J; Yu T; Lin Y; Xia ZS; Yuan YH; Chen QK Pathol Oncol Res; 2015 Jan; 21(1):83-95. PubMed ID: 24875250 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer. Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902 [TBL] [Abstract][Full Text] [Related]
3. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1. Yang J; Tang A; Ma J; Sun X; Ming L Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer. Chen ZQ; Huang LS; Zhu B Dis Markers; 2018; 2018():9845123. PubMed ID: 30647803 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy. Sun Z; Zhang N World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664 [TBL] [Abstract][Full Text] [Related]
6. CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242. Björkman K; Mustonen H; Kaprio T; Kekki H; Pettersson K; Haglund C; Böckelman C Tumour Biol; 2021; 43(1):57-70. PubMed ID: 33935125 [TBL] [Abstract][Full Text] [Related]
7. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459 [TBL] [Abstract][Full Text] [Related]
8. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer. Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284 [TBL] [Abstract][Full Text] [Related]
9. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China. Ma L; Xie XW; Wang HY; Ma LY; Wen ZG Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610 [TBL] [Abstract][Full Text] [Related]
10. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer. Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496 [TBL] [Abstract][Full Text] [Related]
11. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients. Chen Y; Gao SG; Chen JM; Wang GP; Wang ZF; Zhou B; Jin CH; Yang YT; Feng XS Cell Biochem Biophys; 2015 Apr; 71(3):1287-91. PubMed ID: 25486903 [TBL] [Abstract][Full Text] [Related]
12. Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Lai IR; Lee WJ; Huang MT; Lin HH Hepatogastroenterology; 2002; 49(46):1157-60. PubMed ID: 12143226 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. Kim JH; Jun KH; Jung H; Park IS; Chin HM Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination. Emoto S; Ishigami H; Yamashita H; Yamaguchi H; Kaisaki S; Kitayama J Gastric Cancer; 2012 Apr; 15(2):154-61. PubMed ID: 21892754 [TBL] [Abstract][Full Text] [Related]
15. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited. Ma S; Shen L; Qian N; Chen K Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples. Thomas DS; Fourkala EO; Apostolidou S; Gunu R; Ryan A; Jacobs I; Menon U; Alderton W; Gentry-Maharaj A; Timms JF Br J Cancer; 2015 Jul; 113(2):268-74. PubMed ID: 26035703 [TBL] [Abstract][Full Text] [Related]
17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers]. Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Ychou M; Duffour J; Kramar A; Gourgou S; Grenier J Dis Markers; 2000; 16(3-4):105-10. PubMed ID: 11381189 [TBL] [Abstract][Full Text] [Related]
19. Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Yang XQ; Li Y; Chen C; Peng CW; Liu SP; Liu Y Med Oncol; 2011 Sep; 28(3):789-95. PubMed ID: 20373053 [TBL] [Abstract][Full Text] [Related]
20. Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study. Li C; Zhang D; Pang X; Pu H; Lei M; Fan B; Lv J; You D; Li Z; Zhang T EBioMedicine; 2021 Dec; 74():103706. PubMed ID: 34801967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]